Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New Podcast CE Alert: "Medications for Opioid Use Disorder" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Breast Cancer
  5. Treatment

Treatment

  • Anemia (53)
  • Blood Products (5)
  • Breast Cancer (65)
    • Drug Toxicity (44)
    • Natural Medicines/Supplements (2)
    • Prevention/Risk Factors (16)
    • Treatment (10)
  • Cancer (22)
  • Cervical Cancer (18)
  • Chemotherapy (6)
  • Chemotherapy-Induced Adverse Effects (35)
  • Colon Cancer (22)
  • Drugs/Products That May Increase Cancer Risk (119)
  • Gastrointestinal Cancers (33)
  • Hemophilia (4)
  • Hemorrhage (7)
  • Leukemia (1)
  • Lung Cancer (98)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (5)
  • Prostate Cancer (29)
  • Renal Cancer (1)
  • Resources (76)
  • Sickle Cell Disease (5)
  • Skin Cancer (23)
1 - 10 of 10 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Choosing Antidepressants
April 2025
Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and More
May 2024
Chart: Look-Alike/Sound-Alike Medications May 2019
Article: Some women will now use tamoxifen for up to 10 years instead of 5 years February 2013
PL Voices: Tamoxifen for Prevention of Breast Cancer Recurrence February 2013
Commentary: Extending Tamoxifen Therapy to Ten Years: Pros and Cons February 2013
Article: new warnings not to combine tamoxifen with certain SSRIs July 2009
Commentary: Tamoxifen and SSRIs: Is There An Interaction? July 2009
Article: how to prevent or treat bone loss associated with aromatase inhibitors (Femara, Arimidex, etc) July 2008
Article: Some women will get Zometa (zoledronic acid) to prevent recurrent breast cancer July 2008
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved